Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-25 @ 2:11 AM
NCT ID:
NCT01031160
Eligibility Criteria:
* INCLUSION CRITERIA:
Both boys and girls will be recruited for participation in the study. African American youth will be over-sampled to improve population estimates
Study Inclusion Criteria:
All participants previously recruited in the NEXT Generation Health Study are eligible for inclusion in the future assessments.
Next Plus Inclusion Criteria:
Participants are included in the NEXT Plus if they met the criteria for and completed the NEXT survey in Wave 1 and the Wave 1 in-school assessments of height and weight and they and their parents completed the NEXT Plus consent and assent forms.
EXCLUSION CRITERIA:
Survey Exclusion Criteria:
Participants are excluded from participating in the study for any of the following:
* No informed consent from parent(s),
* No informed assent/consent (depending on age) from the participant, or
* Developmental limitations that affect the participant s ability to understand or provide age appropriate responses to the questions posed
Home Visit Exclusion Criteria:
Participants are excluded from participating in NEXT Plus for any of the following:
* No informed consent from parent(s),
* No informed assent/consent from the child,
* Developmental limitations that affect the child s ability to understand or provide age appropriate responses to the questions posed, or
* A blood condition that increases the risk of bleeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
22 Years
Study:
NCT01031160
Study Brief:
Protocol Section:
NCT01031160